Exome sequencing
Analysis of coding regions for studies of rare variants, phenotypic cohorts, cases and families, with processing strategy defined by project.
Research Services
Exome, genome, transcriptome, long-read sequencing by ONT and PacBio and variant analysis with the NeoVar software in custom-designed projects.
Hireable Capabilities
Services can be contracted independently or combined into a single flow, depending on the study's objectives, samples and deliverables.
Analysis of coding regions for studies of rare variants, phenotypic cohorts, cases and families, with processing strategy defined by project.
Broader investigation of coding and non-coding regions, including classes of variants compatible with the chosen design and technology.
RNA sequencing to explore expression, transcripts, splicing, and fusions when the sample, tissue, and scientific question allow.
Long reads with Oxford Nanopore Technologies to address complex regions, phase, structural variants, and other objectives defined in the protocol.
HiFi readings for projects that benefit from high reading accuracy, resolution of complex regions, phase and structural variants.
Analysis software to annotate, filter, prioritize and review variants, organizing the curation of cases and cohorts with traceability.
Project flow
Each step is recorded in the scope so that technical decisions, responsibilities and deliverables remain clear.
Objective, hypothesis, cohort, available samples, term and intended use of data.
Technology selection, quality criteria, analysis, deliverables and technical proposal.
Conference, traceability and evaluation of samples according to the agreed protocol.
Preparation and execution on the platform defined for the study.
Processing, quality control and analysis of variants according to the contracted pipeline.
Files, processed results, report or technical meeting according to the approved scope.
Before the proposal
An initial conversation avoids hiring more data than the study needs — or technology that does not respond to the hypothesis.
Describe the phenomenon to be investigated, the type of comparison and the expected use of the results.
Enter origin, type, quantity, conservation, number of cases and available metadata.
Define whether the project needs primary data, processed files, prioritized variants, reporting or technical support.
Governance
Projects with human samples or data need to consider consent, applicable approvals, privacy, security, and intended use from the outset.
The scope identifies the approvals, consents, and responsibilities required for the project.
Access, transfer, retention and delivery format are aligned according to LGPD and applicable requirements.
Research results do not automatically become diagnostic findings; eventual clinical use requires appropriate process and validation.
Frequently asked questions
Yes. Exome, genome, transcriptome and long-read can be combined when complementary data helps answer the study question. Feasibility is assessed per project.
The platforms have different reading characteristics, accuracy, performance and experimental design. The choice considers the region, variants, samples and expected deliverable.
Yes. The scope may include analysis and prioritization of variants with NeoVar, in addition to the processed files or results defined in the proposal.
Share objective, number and type of samples, technology of interest, desired analysis, timeline, deliverables, and known ethical or regulatory requirements.
No. The timeline depends on the cohort, sample quality, platform, depth, analysis and deliverables. The estimate is formalized after the technical evaluation.
New project
Send the objective, available samples and expected deliverables to begin the technical-scientific evaluation.